Boceprevir

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, PharmD
Boceprevir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Boceprevir is indicated for the treatment of HCV (genotype1, used in combination with peg-INF + ribavirin) in adult patients with compensated liver disease, including cirrhosis.
    • Boceprevir may be used in either treatment-naïve patients or those who have failed previously interferon/ribavirin therapy.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 4, 2018

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Boceprevir ID - 545232 A1 - Smith,Janessa,Pharm.D. BCPS AU - Pham,Paul,PharmD Y1 - 2018/03/04/ PB - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545232/all/Boceprevir ER -